psoriatic arthritis

(redirected from Arthritis, psoriatic)
Also found in: Dictionary, Medical.
  • noun

Words related to psoriatic arthritis

a form of rheumatoid arthritis usually affecting fingers and toes and associated with psoriasis

References in periodicals archive ?
Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.
REMICADE is approved to treat such indications as rheumatoid arthritis, early rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ankylosing spondylitis, plaque psoriasis and ulcerative colitis.
Humira is approved to treat rheumatoid arthritis, psoriatic arthritis, spinal arthritis and Crohn's disease.
ANTI-TNF therapy is a new class of drug to treat severe forms of inflammatory arthritis such as rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Remicade is approved to treat plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, adult Crohn's Disease, pediatric Crohn's disease, ulcerative colitis, and ankylosing spondylitis.
Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, and Ankylosin Spondylitis in India
Finally, they pointed out that the coding system used to identify inflammatory arthritis was unable to distinguish between different types, including rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.
Proteins that inhibit the action of TNF-alpha are currently approved for the treatment of rheumatoid arthritis, psoriatic arthritis and Crohn's disease.
Adalimumab (branded Humira), made by Abbott, a recombinant human monoclonal antibody specific for human tumor necrosis factor that was created through phage display, has become an over $2 billion drug through the accumulation of indications that include: rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and Crohn's disease.
COVA322 is Covagen's lead bispecific FynomAb developed for treatment of patients with rheumatoid arthritis, psoriatic arthritis and other inflammatory diseases.
While no area of pharmacotherapeutics is without need of improvement, the unmet needs for rheumatic diseases such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis have significantly decreased with the availability of TNF inhibitors.
Inflammatory arthritis was identified in 1,518 patients; this included patients with a diagnosis of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondyloarthritis.
With ongoing studies for the treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, golimumab is being studied as a monthly SC injection and an every twelve-week intravenous (IV) infusion (approximately 30-minutes) therapy.
The report provides an in-depth analysis of the top four arthritis therapeutic indications which are osteoarthritis, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis, Furthermore, it also includes the market forecasts and treatment usage patterns of these four therapeutic indications.
New data have prompted an update of a widely cited consensus statement on biologic agents for rheumatic arthritis, psoriatic arthritis, ankylosing spondylitis, and other rheumatic diseases, according to Dr.